Introduction

One of the world's largest provider of swiss Cellular Therapy, Organ-specific and Placenta Extract products.

MFIII of Switzerland is a global anti-aging brand offering a wide range of consumer and practitioner product consisting of supplements, aesthetics and therapeutics for the management of anti-aging diseases and halal the rejuvenation of facial and body aesthetics. MFIII of Switzerland products are manufactured and distributed by its parent company Lab Dom Suisse Inc (Lab Dom) - a world leader in the regenerative medicine and cellular therapy fields.

With a brand heritage originating in 1991, MFIII of Switzerland is armed with an expanding portfolio of anti-aging creations; arefully prepared-form a guarded blend of premium cellular extracts and live cells of the purest and most patent grade - in Switzerland.

Thisincludes a diverse array of natural cellular ingredients - cryogenic live cells, organ-specific cell extracts, nano-filtrated cell extracts, placenta cell extracts and botanical cell extracts.

This premium cellular therapy brand achieved a world-finest at lunch with the development of the first placenta extract oral supplement -PE Softgels - a revolutionary development from the traditional injectable form of cellular therapy.

Another world first was claimed in 2003, with the development of the MFIII Vegetal Placenta Extracts to produce cosmeceuticals in responce to requests from the halal and Middle Eastern markets.

In 2007, a further innovation development in anti-aging solutions was produced with the MFIII Nano Cell Extracts cosmeceutical product, with its innate versatility for direct skin topical application, oral ingestion intradermal or intramuscular injection.

The range has now beenexpanded to include a series of organ-specific nano cell extracts of more than 40 types for therapeutic use.

In 2009 - MFIII Advanced Formula was launched, introducing a higher concentration of bioactive sheep placenta extracts with potent anti-aging capabilities and additional fortification with marine DNA cellular extract.

Today, MFIII of Switzerland has taken on a pioneering role and forefront potition in the global anti-aging industry, evolving into a multiple award-winning brand and delivering trust and unrivalled rejuvenation experience to peaple in pover 70 countries for the past 20 years.

 

Swiss Cellular Therapy:

A natural rejuvenation method originating from Switzerland that has proven effectiveness against aging and chronic diseases

Cellular therapy is an antecedent of modern stem cell biology. It essentially represents the administration of cellular materials from fetal tissues into the human body for therapeutic purposes.

Largely developed by swiss physician Prof.Dr. Paul Niehans in the 1930s, this natural rejuvenation method is closelyassociated with the principle of " Similia Similibus Curantur" or "Like Cures Like" - eminently stated by 16th century Swiss physician and philosopher Paracelsus. Based on this principle, cell therapists worldwide specifically precribe healthy and bioactive cellular materials, derived from the individualised patho-physiological diagnosis of patients, to rebuild or revitalize aging or diseased organs of the same tissue type.

Upon implantation, these young cells or cell extracts are broken down into their basic elements such as enzymes, polypeptides, deoxyribonucleic acids, ribonucleic acids and other basic organic substances, so that these elements are reused by the cells, tissues and organs of the body. Similar to the modern science of stem cell therapy, the healing mechanism of these cellular materials involves the replacement and regeneration of old or malfunctioning cells, thereby stimulating the growth and function of tissues in our body.

with over 80 years of research and over 8 million clinical applications worldwide to date, cellular therapy is scientifically proven to be effective in the delay of human aging. It is a natural rejuvention method that bolsters the body's regenerative ability against premature cell death or malfunction of specific cell types, which are often patho-physiological factors that would ultimately lead to a systemic disease or disorder.

 

Revitalization with Cell Therapy heal

Cell Therapy starts with the selection of specific organ cells from a foetal animal bred specifically for this purpose. In Live Cell Therapy, these vigorous young cells, with their vital life force still active, are injected into a human host. Since foetal cells have no antigens, they are not recognised as foreign by the host body. According to Professors Dr. Paul Niehan's and Dr. Franz Schmid's proven theories, they circulate from the site of the injection until they recognise and congregate at the human counterpart of the organ from which they were taken (liver cells go to the liver, sex cells go to the sexual organs, heart cells go to the heart, etc). These young cells which are functional organ specific but not species specific, imprint their vigor upon old, tired and degenerating cells, stimulating them to function with renewed efficiency. The organ itself then regains and retains its vigor and vitality. Some Cell Therapists feel that the most important result of Cell Therapy is the revitalization of the body's immune system and defense mechanisms.

When damage occurs to the cells that make up the various tissues and organs involved in the immune system (either through the ageing process or from environmental poisons), the body becomes defenceless against both external agression and invasion and internal degeneration. Damage to the organs of the immune system may be reversed through revitalization and regeneration with Cell Therapy. These new and energetic fresh cells act quickly and effectively to stimulate the body's defense mechanisms. There is enormous interest in the use of this therapy to dramatically slow down the ageing process and to regain your health, your vitality and your physical power. All of us want to live long quality life, no one wants to grow old.

MFIII of Switzerland is NOT a DRUG as it does not contain any chemical but is solely a nutritional supplement touted by many as the 'Rolls Royce of all nutritional supplements'. MFIII of Switzerland is totally safe and can be used in conjunction with any other vitamin or nutritional supplement.

Thousands of medical research and reports on Cell Therapy's therapeutic benefits & over 8 million recipients by 6,000 doctors worldwide over the last 75 years.

HOW DOES MF3 WORK ?

MFIII of Switzerland hi-tech PE Softgels are fully researched and developed in Switzerland and Germany. The method employed in unique softgel capsules produces cells which remain biologically active [a proven technique for gently conserving biological substances] without damaging the effectiveness of the valuable, big, bio-active matter. The exact dosage of the cell preparations can be accurately measured and the sterility controlled. Cell Therapy is a well known process in the world that has been proven safe and effective in slowing down the ageing process and dramatically regaining your health, vitality and physical power. MFIII of Switzerland softgels are deemed the most perfected anti-ageing and cell-activating oral supplement from more than 20 years of research and development.

MFIII of Switzerland softgels being enteric coated by-pass the stomach and dissolve in the small intestine whereby the active ingredients are fully absorbed by the body. The advantage of dissolution in the small intestine instead of in the stomach is that it avoids the destruction of active peptides and their functions by gastric acid, thereby ensuring the bioavailability of the cell elements consumed. It is currently the most advanced bio-technological product with a very high metabolic activity. It's active ingredients are small molecular peptides which are absorbed by the body without losing their effects to induce regenerative functions. The marine cell extracts of MFIII of Switzerland extracts are from cell culture. They are very pure raw materials without any foreign content and are 99% water-soluble.

MFIII of Switzerland - THE SWISS IP SECRET IN PLACENTAL AND DNA CELL EXTRACTION

Laboratoires Dom AVMM Suisse, the Swiss formulators and developers of MFIII of Switzerland, holds the one and only Swiss licensed method of extraction of placental extraction. The Swiss believe that, in order to maintain the bioactiveness of the active substance of cell extracts, it can only be done with their unique, closely-guarded, Swiss secret of cold enzymatic acid process during extraction without without the destructive effects of heating from 125 celcius to 180 celcius as used in common sterilization process. Hence, no cell extracts are the same because the methods of extraction process are very different. Production of current Placenta Extracts supplement in the markets are via conventional methods being:
(1) GROUNDING which leave impurities, accumulated and unfiltered heavy metals;
(2) LYOPHILIZATION where the cellular wall structure of the cells are unavoidably damaged during the lyophilization process, rendering a high loss of the marine cell extracts' efficacy and effectiveness;
(3) STERILIZATION PROCESS where heating between 125 celcius to 180 celcius virtually kills off all natural bio-activeness of any good marine cell extracts. MFIII Swiss cell extracts supplement with its unique extraction method is more bio-active and readily available to the users upon ingestion with its fully-soluble, spray-dried material in controlled air environment throughout its unique proprietary Enzymatic Digestion process. There are lots of differences between a Rolls Royce and a Mini...

OUR MF3 PLACENTAL EXTRACTION

MFIII of Switzerland only utilises 1st Grade Government Certified DNA Cell Extracts and they are processed by its (MFIII) own processing plant in New Zealand. In comparision with any other cell extracts products, MFIII of Switzerland softgels will not supply artificial hormones to our bodies, which would affect our own hormone production. Dependency on Hormone Therapy may be effective during treatment. However, it will lose its effects when discontinued. This can be dangerous as it affects the natural balance of the endocrine system. Since MFIII of Switzerland is protein-free, the risk of allergy is highly minimized as the chance of attacking a foreign body is negligible. The active substances in MFIII of Switzerland are extracted with hi-tech biotechnological processes. These extracts so-called homologous elements, entere our bodies to contribute enormously to revitalization through activation and regeneration of our damaged and ageing cells. The ratio of active ingredients in MFIII of Switzerland is set after prolonged researches and trials in various scientific fields towards achievement of the best concentration of the active ingredients. Both the inner ingredients and outside coating of MFIII of Switzerland capsules are stabilised. MFIII of Switzerland products are all extracted from small peptide fractions with the big molecules of fat, protein and hormones removed. They are further cultivated by Cell Culture with the end results of the active parts separated and purified. They are thus very pure and not contain any other unnecessary ingredient.

Anti Ageing is only a general term which represents a whole process. With age advancement, the functions of our organs deteriorate. Chronic diseases set in. When the body feels uncomfortable, symptoms such as lethargy, fatique, stress, insomnia, poor concentration, weak memory, depression, irritability, nervousness, dizziness, headache become apparent. These can be greatly reduced with MFIII of Switzerland. This also applies to menopausal symptoms such as hot flashes, night sweats, mood swings, anxiety, depression , dehydration of skin which can also be greatly alleviated. No side effects will occur for long-term maintenance since the bio-molecules metabolize, degenerate and are excreted via the same pathways as endogenous products.

CLINICAL STUDIES

Clinical Test 1 - BIO-HC Laboratories, Clinical Report No. TAO 01.1099, Pessac, France 2001

Lethal Doses (LD50) Toxicity Tests

Bio HC is one of Europe's largest and most sophisticated Clinical Test research centre in Pessac, France under GLP (Good Laboratories Practice) and GCP (Good Clinical Practise) conditions. Bio HC in Vitro Department comprises a group of dynamic and experienced experts. The professionals include physicians, pharmacists, dermatologists, allergists, biochemists and bacteriologists. In order to ensure MFIII of Switzerland is totally harmless and have scientific objectivity, Bio HC in Vitro Department conducted and validated toxicological and pharmacological studies on MFIII of Switzerland. The test report was further attested and audited by PHYCHER Bio development in France. Then MFIII of Switzerland was also further analysed by 3 other Swiss Research bodies.

Clinical Test 2 - Pharmaceutical Research, Company Inc (PRC) USA, Exton, USA 2002

Safety Profile Assessment

Pharmaceutical Research Company, Incorporated (PRC) situated in Exton, Philadelphia USA, are International Pharmaceutical Consultants to many Multi National Companies on Biotechnology, Pharmaceuticals, FDA Regulations, Analysis and Research.

Various samples of different batches of production of MFIII of Switzerland PE Softgels were further despatched across the continent to another independent New Zealand biotech laboratory, namely Canterbury Health Laboratories. Here, under The Steroid and Immunology Unit headed by Professor John Lewis, PhD Steroid BioChemist, the samples were thoroughly tested on the basis of dry weight and volume. Results were then re-directed back to the USA for the report on safety assessment under the professional guidance of American Professor Dr. Pardeep Gupta, Associate Professor, of Pharmacy at University of the Sciences, Philadelphia, USA.

With a broad reference of over 500 databases on chemical, pharmaceuticals, medicine and biotechnology from USA, Europe, Japan and NIH (National Institute of Health), and with professional expertise, PRC certified and authenticated on January 28, 2003 that Marine Cell Extracts (MFIII of Switzerland PE Softgels) is SAFE for human consumption.

Clinical Test 3 - Sun Yat-Sun, University Hospital, Guang Chou, China 2005

Independent Clinical Research and Testing

This was carried out by Sun-Yat-Sun University Hospital, one of two of China's renowned universities for clinical trials. The findings were published in Chinese Journal and the Dermatology magazine of one Anti-ageing Association.

Clinical Test 4 - State Food & Drug, Administration, China, Beijing, China 2005/2006

 

China SFDA Safety, Toxicity & Clinical Testing Approval

One of the pre-requisites for oral supplement approvals in China was their very stringent independent SFDA government laboratory testing for safety, toxicity and efficacy. MFIII went through these vigourous testings, and trials, one by one. MFIII was clinically tested by Beijing Ke Siang Ba Ya Medical Research Technology Company and approved by China SFDA. In early 2006, the approval SFDA Report No: 200606008 on all-in testings was successfully out.

 

Clinical Test 5 - Lab. Intercosmetica - Zepter Group, Switzerland 2005/2006

Swiss Independent Randomised Double-Blind Placebo* Controlled Study

was headed by Professor Dr. Alain Begiun, commitee of the Swiss Society of Cosmetic Chemists (SCC) and a team of Swiss professional clinicians. Clinical Report No. CTE 23A, The Proven Clinical Study, was published and presented in Medical Journals and at Medical Dermatology Conference of Anti-ageing in Paris, Europe in October 2006.

 

 

Clinically proven evidence of a skin replenishment effect

Computerized ultrasound epidermis and dermis density

Example of dermis density increase on the right, treated forearm (volunteer #57, Vol, age 31)

CLINICALY PROVEN EVIDENCED BASED SKIN REJUVENATION EFFECTS

Within 2 months the older group shows a skin rejuvenation level of about 20 years, based on the epidemis + dermis density.

Demography

* Venue of study: Neuchatel Switzerland
* Time: September, 2005 to January 2006
* 2 groups of volunteers: Test group, Placebo group
* Healthy women, Caucasian skin type, Various races
* Skin phototype II (Fitzpatrick)
* Ages: Group ranging from 20-60 years, mean 41
* Volunteers nor research conducting personnel are aware which is the real PE Softgels nor its name or a Placebo as softgels looks totally alike.

 

 

Study on human volunteers (in vivo)

* Double-blind placebo-controlled clinical study
* 58 women aged 20-60
* No study-related side-effects reported
* 11 skin bioengineering parameters studied

Study on human volunteers (in vivo) (2)

* Noticeable effects already after four weeks
* Significant reduction of microscars after 3 months
* Improved skin smoothness
* Improved skin firmness (=dermis density)
* Reduced fine lines and wrinkles

Clinically Proven evidence of a skin smoothing effect

Computerized skin profilometry
(on skin microrelief, average roughness, forearm etc)

CONCLUSION ON RESULTS
Selected example of skin surface smoothing (vol. #12, age 46):

 

A stepwise skin surface improvement can be followed up visually:

- SMOOTHER SKIN! - LESS DRY SKIN!
(less white areas)